INDOCO REMEDIES
Back to Cashflow Statement
|
INDOCO REMEDIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹280 Cr | ₹23 Cr | ₹-44 Cr | ₹-30 Cr | ₹-64 Cr |
What is the latest Cash Flow from Financing Activities ratio of INDOCO REMEDIES ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹280 Cr |
Mar2023 | ₹23 Cr |
Mar2022 | ₹-44 Cr |
Mar2021 | ₹-30 Cr |
Mar2020 | ₹-64 Cr |
How is Cash Flow from Financing Activities of INDOCO REMEDIES Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹280 Cr | 1,129.76 | |
Mar2023 | ₹23 Cr | Positive | |
Mar2022 | ₹-44 Cr | Negative | |
Mar2021 | ₹-30 Cr | Negative | |
Mar2020 | ₹-64 Cr | - |
Compare Cash Flow from Financing Activities of peers of INDOCO REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDOCO REMEDIES | ₹2,920.0 Cr | 0.1% | 7.5% | 0.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,551.0 Cr | 0.4% | 1.8% | 4.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,704.0 Cr | -1.1% | 0.1% | 45.6% | Stock Analytics | |
CIPLA | ₹123,675.0 Cr | 3.8% | 1.2% | -1.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,925.0 Cr | 2.2% | 11.7% | 11.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,626.0 Cr | 1.4% | -3.3% | -7.2% | Stock Analytics |
INDOCO REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDOCO REMEDIES | 0.1% |
7.5% |
0.1% |
SENSEX | -0.4% |
-1.6% |
1.3% |
You may also like the below Video Courses